Literature DB >> 23319639

STOP gene Phactr4 is a tumor suppressor.

Nicole L Solimini1, Anthony C Liang, Chunxiao Xu, Natalya N Pavlova, Qikai Xu, Teresa Davoli, Mamie Z Li, Kwok-Kin Wong, Stephen J Elledge.   

Abstract

Cancer develops through genetic and epigenetic alterations that allow unrestrained proliferation and increased survival. Using a genetic RNAi screen, we previously identified hundreds of suppressors of tumorigenesis and/or proliferation (STOP) genes that restrain normal cell proliferation. Our STOP gene set was significantly enriched for known and putative tumor suppressor genes. Here, we report a tumor-suppressive role for one STOP gene, phosphatase and actin regulator 4 (PHACTR4). Phactr4 is one of four members of the largely uncharacterized Phactr family of protein phosphatase 1 (PP1)-and actin-binding proteins. Our work suggests that Phactr4 restrains normal cell proliferation and transformation. Depletion of Phactr4 with multiple shRNAs leads to increased proliferation and soft agar colony formation. Phactr4 acts, in part, through an Rb-dependent pathway, because Rb phosphorylation is maintained upon growth factor withdrawal in Phactr4-depleted cells. Examination of tumor copy number analysis and sequencing revealed that PHACTR4 is significantly deleted and mutant in many tumor subtypes. Furthermore,cancer cell lines with reduced Phactr4 expression exhibit tumor suppressor hypersensitivity upon Phactr4 complementation,leading to reduced proliferation, transformation, and tumor formation. Thus, Phactr4 acts as a tumor suppressor that is deleted and mutant in several cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319639      PMCID: PMC3562831          DOI: 10.1073/pnas.1221385110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

2.  Second-generation shRNA libraries covering the mouse and human genomes.

Authors:  Jose M Silva; Mamie Z Li; Ken Chang; Wei Ge; Michael C Golding; Richard J Rickles; Despina Siolas; Guang Hu; Patrick J Paddison; Michael R Schlabach; Nihar Sheth; Jeff Bradshaw; Julia Burchard; Amit Kulkarni; Guy Cavet; Ravi Sachidanandam; W Richard McCombie; Michele A Cleary; Stephen J Elledge; Gregory J Hannon
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

3.  Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins.

Authors:  Patrick B Allen; Audrey T Greenfield; Per Svenningsson; Derek C Haspeslagh; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

4.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

5.  Scapinin, a putative protein phosphatase-1 regulatory subunit associated with the nuclear nonchromatin structure.

Authors:  Junji Sagara; Tsukasa Higuchi; Yukiko Hattori; Mie Moriya; Haritha Sarvotham; Hiroshi Shima; Haruki Shirato; Kunimi Kikuchi; Shunichiro Taniguchi
Journal:  J Biol Chem       Date:  2003-08-17       Impact factor: 5.157

Review 6.  Principles of tumor suppression.

Authors:  Charles J Sherr
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

7.  A resource for large-scale RNA-interference-based screens in mammals.

Authors:  Patrick J Paddison; Jose M Silva; Douglas S Conklin; Mike Schlabach; Mamie Li; Shola Aruleba; Vivekanand Balija; Andy O'Shaughnessy; Lidia Gnoj; Kim Scobie; Kenneth Chang; Thomas Westbrook; Michele Cleary; Ravi Sachidanandam; W Richard McCombie; Stephen J Elledge; Gregory J Hannon
Journal:  Nature       Date:  2004-03-25       Impact factor: 49.962

Review 8.  Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.

Authors:  Jesús Gil; Gordon Peters
Journal:  Nat Rev Mol Cell Biol       Date:  2006-09       Impact factor: 94.444

9.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

Review 10.  Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.

Authors:  Manuela Santarosa; Alan Ashworth
Journal:  Biochim Biophys Acta       Date:  2004-06-07
View more
  9 in total

1.  TMED2 binding restricts SMO to the ER and Golgi compartments.

Authors:  Giulio Di Minin; Markus Holzner; Alice Grison; Charles E Dumeau; Wesley Chan; Asun Monfort; Loydie A Jerome-Majewska; Henk Roelink; Anton Wutz
Journal:  PLoS Biol       Date:  2022-03-30       Impact factor: 8.029

2.  Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(∗) in SCC progression.

Authors:  Yejing Ge; Liang Zhang; Maria Nikolova; Boris Reva; Elaine Fuchs
Journal:  Nat Cell Biol       Date:  2015-11-30       Impact factor: 28.824

3.  Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.

Authors:  Charles J Cho; Jaeeun Jung; Lushang Jiang; Eun Ji Lee; Dae-Soo Kim; Byung Sik Kim; Hee Sung Kim; Hwoon-Yong Jung; Ho-June Song; Sung Wook Hwang; Yangsoon Park; Min Kyo Jung; Chan Gi Pack; Seung-Jae Myung; Suhwan Chang
Journal:  Dig Dis Sci       Date:  2018-04-25       Impact factor: 3.199

4.  Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus.

Authors:  Marco Gaviraghi; Claudia Vivori; Yerma Pareja Sanchez; Francesca Invernizzi; Angela Cattaneo; Benedetta Maria Santoliquido; Michela Frenquelli; Simona Segalla; Angela Bachi; Claudio Doglioni; Vicent Pelechano; Davide Cittaro; Giovanni Tonon
Journal:  EMBO J       Date:  2018-10-29       Impact factor: 11.598

5.  Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.

Authors:  Traver Hart; Kevin R Brown; Fabrice Sircoulomb; Robert Rottapel; Jason Moffat
Journal:  Mol Syst Biol       Date:  2014-07-01       Impact factor: 11.429

6.  Phactr3/scapinin, a member of protein phosphatase 1 and actin regulator (phactr) family, interacts with the plasma membrane via basic and hydrophobic residues in the N-terminus.

Authors:  Akihiro Itoh; Atsushi Uchiyama; Shunichiro Taniguchi; Junji Sagara
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

7.  Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab.

Authors:  Rika Fujii; Eitan R Friedman; Jacob Richards; Kwong Y Tsang; Christopher R Heery; Jeffrey Schlom; James W Hodge
Journal:  Oncotarget       Date:  2016-06-07

8.  "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Christopher McGovern; Eric Wafula; Claude dePamphilis; Morgan Meckley; Joyce Wong; Luke Stewart; Christopher D'Jamoos; Naomi Altman; Yuka Imamura Kawasawa; Zhen Du; Loren Honaas; Thomas Abraham
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

9.  Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer.

Authors:  Maritere Uriostegui-Arcos; Rodrigo Aguayo-Ortiz; María Del Pilar Valencia-Morales; Erika Melchy-Pérez; Yvonne Rosenstein; Laura Dominguez; Mario Zurita
Journal:  Open Biol       Date:  2020-06-17       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.